Endocrine therapy use and cardiovascular risk in postmenopausal breast cancer survivors

OBJECTIVE: Examine the effect of tamoxifen and aromatase inhibitors (AIs) on the risk of 12 clinically relevant cardiovascular outcomes in postmenopausal female breast cancer survivors. METHODS: We carried out two prospective cohort studies among postmenopausal women with breast cancer in UK primary...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Heart
Autori principali: Matthews, Anthony A, Peacock Hinton, Sharon, Stanway, Susannah, Lyon, Alexander Richard, Smeeth, Liam, Lund, Jennifer L, Bhaskaran, Krishnan
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Publishing Group 2021
Soggetti:
Cardiac Risk Factors and Prevention
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8327412/
https://ncbi.nlm.nih.gov/pubmed/33177117
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/heartjnl-2020-317510
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi